Pakistan–China investment conference focuses on six key pharmaceutical sub-sectors, aims to boost investment: Kamal

ISLAMABAD, Jul 22 (APP): Federal Minister for National Health Services, Regulations and Coordination, Syed Mustafa Kamal on Wednesday stated that special attention was paid to six important pharmaceutical sub-sectors in recent “Pakistan-China B2B Investment Conference 2026”, aiming to promote investment, technology transfer and local industry in Pakistan.

While addressing a press conference here, Kamal appreciated the Ministry of Health team for its instrumental role, which led to the successful completion of the “matchmaking” process between Pakistani and Chinese companies.

“The Ministry of Health play an effective and successful role during conference, due to which 240 delegations and 140 Chinese companies participated in the two-day conference, while 340 bilateral business meetings were held,” he said.

The Minister noted that during the conference, 22 companies signed agreements worth 629.5 million US dollars, while Memoranda of Understanding (MoUs) worth 800 million US dollars were also signed.

He added that regular communication and consultation are now underway with these companies to implement practical projects.

He highlighted that health sector is sensitive and ever-growing as the population of Pakistan is consistently increasing and it required experienced people to serve.

While appreciating the services of the Islamabad Police during the conference, he said the visiting delegations were well looked after from their arrival at the airport to their accommodation and throughout all other arrangements, adding that these efforts earned Pakistan international appreciation.

While talking about reforms in health sector, he highlighted the online system introduced in the Drug Regulatory Authority of Pakistan (DRAP), which would eliminate the hindrances in registration process of medical related process, devices and others.

He vowed to fully digitize the DRAP within the next year.

He further noted that all 13 vaccines used in Pakistan completely imported, underscoring that the government has prepared the country’s first national vaccine policy, which will pave the way for local vaccine production.

He also highlighted that currently, Pakistan manufactures 85 percent of its own medicines, and exporting to almost 52 countries.

He added that about 95 percent of the raw materials used for the manufacture of medicines are imported.

While concluding, he showed government optimism to strengthen the Pakistan health sector by boosting local production, which would benefit the people.